StockData

EnerSyn Global vs DataMeds AI

ESYN and MEDS side by side, both in wholesale trade-non-durable goods. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ESYN and MEDS compare

EnerSyn Global is the larger company, worth 4.6 times as much as DataMeds AI ($9.0M against $2.0M).

EnerSyn Global grew revenue faster over the last twelve months (−68.5% versus −77.5% for DataMeds AI).

DataMeds AI keeps more of each dollar of sales as profit, with a net margin of −565% compared with −680% at EnerSyn Global.

EnerSyn Global scores higher on the StockData Score (6 against 1 for DataMeds AI), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricESYNMEDS
Size and price
Market cap$9.0M$2.0M
Share price$1.17$0.640
Change, 1 year−32.4%−98.0%
Beta (5Y)0.100.34
Employees435
StockData Score
Total score6 (better)1
Valuation score01 (better)
Growth score1 (better)0
Performance score00
Health score5 (better)0
Dividend score00
Valuation
P/S23.2×0.3× (better)
P/B3.3×–
FCF yield−10.6%–
Growth
Revenue growth (TTM)−68.5% (better)−77.5%
Profitability
Gross margin59.2% (better)−92.1%
Operating margin–−548%
Net margin−680%−565% (better)
FCF margin−245%–
Return on equity−88.9% (better)−1707%
Return on invested capital–−153%
Financial health
Debt / equity0.00–
Interest coverage–−6.2×
Current ratio1.82 (better)0.14
Altman Z-score0.70 (better)−8.90
Piotroski F-score4 (better)1
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions1.1%1.7%
Insider net buying, 12 months$402K–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.